🇺🇸 FDA
Pipeline program

armodafinil

C10953/4024/ES/US

Approved small_molecule completed

Quick answer

armodafinil for Sleep Disorders is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Sleep Disorders
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials